Navigation Links
Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'
Date:9/22/2008

- 60 percent say they are not risk takers with their health, yet up to

one-third of those skip critical health screenings - 42 percent are at elevated risk for cardiovascular events, yet 20 percent of those have not spoken with their physician about preventive benefits of

regular low-dose aspirin

MORRISTOWN, N.J., Sept. 22 /PRNewswire/ -- A new survey of men and women age 40 and older in the United States reveals a significant gap between people's desire to avoid taking risks with their health, and the percentage who knowingly skip critical health screenings. Overall, 60 percent indicated they weren't risk takers with their health. Yet, 25 percent of those who think they play it safe admitted to skipping routine mammograms or prostate cancer screenings, with 30 percent skipping colonoscopies and other screenings after the age of 50.

When it comes to the nation's number one killer, cardiovascular disease (CVD), as many as 42 percent of those surveyed were determined to be at elevated CVD risk using a formula that is based in part on the Framingham Risk Calculator*. If this survey outcome were to be applied to the total populations of men over 40 and women over 50 it could mean that as many as 47.8 million people are at elevated CVD risk**. Among those at elevated risk, as many as one in five have not spoken to their physicians about the preventive benefits of low-dose aspirin therapy.

"Knowing your cardiovascular risk and taking appropriate steps to lower it can decrease the number of heart attacks and strokes suffered in this country every year," said Dr. Nieca Goldberg, clinical associate professor of medicine and medical director of New York University's Women's Heart Program and author of Dr. Nieca Goldberg's Complete Guide to Women's Health. "Patients need to talk to their doctor about proven simple prevention strategies, like taking daily low-dose aspirin, diet and exercise. If more at-risk
'/>"/>

SOURCE Bayer Consumer Care
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
9. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
10. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
11. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).../PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (...y") today announced updated results from a Phase I...h sarcomas metastatic to the lung in a poster pres...logy Society Meeting held in Miami Beach, Florida,..., entitled "A Phase II Study of Intravenous REOLYS...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personal...t to take place on February 22-24, 2010 in Philade...rence we will highlight key issues in forming part...ir experiences. , Minneap...r Arrowhead’s 2010 Personalized Medicine Pa...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)..., Nov. 5 DSM Pharmaceutical Produc...g alliance with Galenix, Saint Jean D,Illac, Franc...e manufacturing partner for Galenix commercial pro...l collaborate on business development opportunitie... based on the strength of Galenix in drug product ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...s Pharma, the,Danish biopharmaceutical company dev...at Keith McCullagh, President and Chief Executive,...pany and its goals for,2008 at the Biotechnology I...Conference in New York, today, Monday February 11t...ral European Time). The conference is,being held a...
...28, The Royal,Marsden Hospital (Sutton, Surrey, UK...lated Arc Therapy (VMAT)* treatment in the world u...e the treatment, the hospital,used its existing El...n,linear accelerator control system., (Logo: htt...GO ), VMAT takes Intensity Modulated Radiation T...
...0 Doses of the CDC,s National Strategic...OLIS, Feb. 11 Sentry Logistic Solutions,announced...ention (CDC),signed a contract to outsource storag...ve of the influenza virus vaccine. Sentry will war...ses from its pharmaceutical cold,chain logistics c...
Other Biology Technology:Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 3
(Date:11/5/2009)...hers (NABT) will recognize Leonard C. Yannielli, p...y Community College (NVCC) in Waterbury, Connectic... the NABT annual professional development conferen...ado. , The Evolution Education Award is cosponso...es,(AIBS) and Biological Sciences Curriculum Stud...
(Date:11/4/2009)...luctant to officially endorse green tea as a cance...out its protective effects, including results of a...h , a journal of the American Association for Canc... cancer. , Vassiliki Papadimitrakopoulo, M.D., ...c/Head and Neck Medical Oncology at the University...
(Date:11/4/2009)...od obesity in the United States is reaching epidem...tising on daytime and prime time television devote...about the role television plays in obesity, a stud...f Nutrition Education and Behavior examines how f... contributor to the problem. , Researchers at th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
...r gene has been discovered by scientists at the Lu...tic Surgery Clinic at the Sahlgrenska Academy in S...tain hereditary deformity syndrome run a nearly tw...r than expected. , Several research teams around ...ary breast cancer genes, but thus far few have bee...
...ng Project, funded by the National Institute of Al...National Institutes of Health (NIH), announced tod...ire genetic blueprints of more than 2,000 human an...d the world have been completed and the sequence d...information will help scientists understand how in...
...of York have won a grant of £110,000 to investigat...sease. , Dr Jason Lynam and Dr Ian Fairlamb, of t... awarded the funding by the Leverhulme Trust for a...for the controlled release of carbon monoxide into...inflammatory, and they want to explore its potenti...
Other Biology News:New hereditary breast cancer gene discovered 22,000 influenza virus genomes now completed and publicly accessible 2Research to spotlight carbon monoxide benefits 2
Silencer siRNA Starter Kit from Ambion
...successful cell culture or fermentation is the abi...ocess, and make rapid adjustments in response to c...ry Analyzers provide immediate analysis of key nut... fermentation media. BioProfile analyzers are full...
...s Routine Testing Laboratory (RTL) can provide you...,,Microbial method development and validation...ditions of your GMP manufacturing environment ,A...,We offer a full spectrum of microbiological se...
...s a 20 amino acid synthetic peptide whose sequence...e sequence of this peptide is (amino to carboxy te... - V - P - N - E - V - L - G - P - E133 (C) (The C...njugation and is not a part of the native rat SAP9...
Biology Products: